• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2B型多发性内分泌腺瘤及相关散发性肿瘤中RET原癌基因酪氨酸激酶结构域内的点突变。

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

作者信息

Eng C, Smith D P, Mulligan L M, Nagai M A, Healey C S, Ponder M A, Gardner E, Scheumann G F, Jackson C E, Tunnacliffe A

机构信息

Department of Pathology, University of Cambridge, UK.

出版信息

Hum Mol Genet. 1994 Feb;3(2):237-41. doi: 10.1093/hmg/3.2.237.

DOI:10.1093/hmg/3.2.237
PMID:7911697
Abstract

The susceptibility loci for the three multiple endocrine neoplasia (MEN) type 2 syndromes have been mapped to the region of chromosome 10q11.2 containing the RET proto-oncogene, which codes for a receptor tyrosine kinase. The majority of MEN 2A and familial medullary thyroid carcinoma results from missense mutations within one of five cysteine codons in the extracellular domain of the RET proto-oncogene. We now report a missense mutation, resulting in the substitution of a threonine for a methionine at codon 918 in the tyrosine kinase catalytic domain, in the germline of 26 of 28 apparently distinct families with MEN 2B. DNA from five of 13 apparently sporadic MTC and one of 12 apparently sporadic phaeochromocytomas harboured a similar mutation, but the corresponding germline DNA was wildtype in each case.

摘要

三种2型多发性内分泌肿瘤(MEN)综合征的易感基因座已被定位到10q11.2染色体区域,该区域包含RET原癌基因,其编码一种受体酪氨酸激酶。大多数MEN 2A和家族性甲状腺髓样癌是由RET原癌基因细胞外结构域五个半胱氨酸密码子之一内的错义突变引起的。我们现在报告在28个明显不同的MEN 2B家族中的26个家族的种系中存在一个错义突变,该突变导致酪氨酸激酶催化结构域第918位密码子的甲硫氨酸被苏氨酸替代。13例明显散发的甲状腺髓样癌中的5例以及12例明显散发的嗜铬细胞瘤中的1例的DNA含有类似突变,但相应的种系DNA在每种情况下均为野生型。

相似文献

1
Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.2B型多发性内分泌腺瘤及相关散发性肿瘤中RET原癌基因酪氨酸激酶结构域内的点突变。
Hum Mol Genet. 1994 Feb;3(2):237-41. doi: 10.1093/hmg/3.2.237.
2
Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.1995年鲁道夫·魏尔啸奖。RET原癌基因突变分析在2型多发性内分泌腺瘤病(MEN 2)基因携带者诊断以及散发性和家族性甲状腺髓样癌与嗜铬细胞瘤鉴别中的作用
Verh Dtsch Ges Pathol. 1995;79:L-LV.
3
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.一种与2B型多发性内分泌腺瘤病和散发性甲状腺髓样癌相关的RET原癌基因突变。
Nature. 1994 Jan 27;367(6461):375-6. doi: 10.1038/367375a0.
4
Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain.散发性甲状腺髓样癌患者RET原癌基因的分子分析:细胞外富含半胱氨酸结构域中的一种新型点突变。
Eur J Endocrinol. 1997 Apr;136(4):423-6. doi: 10.1530/eje.0.1360423.
5
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.散发性甲状腺髓样癌及一个家族性甲状腺髓样癌(FMTC)家系中RET原癌基因酪氨酸激酶结构域的一种新型点突变。
Oncogene. 1995 Feb 2;10(3):509-13.
6
Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.2型多发性内分泌肿瘤综合征、相关散发性肿瘤及先天性巨结肠症中RET原癌基因的突变
Hum Mutat. 1997;9(2):97-109. doi: 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M.
7
Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.RET原癌基因第918密码子的突变与散发性甲状腺髓样癌的不良预后相关。
J Clin Endocrinol Metab. 1995 Oct;80(10):3088-90. doi: 10.1210/jcem.80.10.7559902.
8
[Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].通过检测RET原癌基因突变携带者对2型多发性内分泌肿瘤(MEN 2)进行早期诊断
Medicina (B Aires). 1998;58(2):179-84.
9
Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".通过RET原癌基因突变分析区分散发性和遗传性甲状腺髓样癌(MTC)。“奥地利多内分泌腺瘤研究小组(SMENA)”
Int J Cancer. 1996 Aug 22;69(4):312-6. doi: 10.1002/(SICI)1097-0215(19960822)69:4<312::AID-IJC13>3.0.CO;2-7.
10
Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome).2A型多发性内分泌腺瘤病(西普尔综合征)中RET原癌基因的突变。
Endocr J. 1995 Aug;42(4):527-36. doi: 10.1507/endocrj.42.527.

引用本文的文献

1
Case Report: A novel likely pathogenetic variant of the gene in multiple endocrine neoplasia type 1.病例报告:多发性内分泌腺瘤病1型中该基因一种新的可能的致病变异。
Front Endocrinol (Lausanne). 2025 May 12;16:1551087. doi: 10.3389/fendo.2025.1551087. eCollection 2025.
2
Mechanisms of resistance to RET-directed therapies.对RET靶向治疗的耐药机制。
Endocr Relat Cancer. 2025 Jan 10;32(2). doi: 10.1530/ERC-24-0224. Print 2025 Feb 1.
3
Well-defined survival outcome disparity across age cutoffs at 45 and 60 for medullary thyroid carcinoma: a long-term retrospective cohort study of 3601 patients.
45 岁和 60 岁年龄界限明确的生存结果差异横跨甲状腺髓样癌:3601 例患者的长期回顾性队列研究。
Front Endocrinol (Lausanne). 2024 Jun 14;15:1393904. doi: 10.3389/fendo.2024.1393904. eCollection 2024.
4
Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targeting in Thyroid Cancer.RET/PTC 和 TERT 启动子突变共存预示甲状腺癌预后不良,但 RET 和 MEK 靶向治疗有效。
J Clin Endocrinol Metab. 2024 Nov 18;109(12):3166-3175. doi: 10.1210/clinem/dgae327.
5
Clinical Activity of Selpercatinib in RET-mutant Pheochromocytoma.塞尔帕替尼在RET突变型嗜铬细胞瘤中的临床活性
J Clin Endocrinol Metab. 2025 Feb 18;110(3):e600-e606. doi: 10.1210/clinem/dgae283.
6
MEN 2B CASES WITH ATYPICAL PRESENTATION, UNUSUAL CLINICAL COURSE AND A LITERATURE REVIEW.具有非典型表现、异常临床病程的2B型多发性内分泌腺瘤病病例及文献综述
Acta Endocrinol (Buchar). 2023 Apr-Jun;19(2):260-266. doi: 10.4183/aeb.2023.260. Epub 2023 Oct 27.
7
Progress in Thyroid Cancer Genomics: A 40-Year Journey.甲状腺癌基因组学的进展:四十年的历程。
Thyroid. 2023 Nov;33(11):1271-1286. doi: 10.1089/thy.2023.0045. Epub 2023 Sep 4.
8
Prominent corneal nerves in pure mucosal neuroma syndrome, a clinical phenotype distinct from multiple endocrine neoplasia type 2B.纯黏膜神经瘤综合征中突出的角膜神经,与多发性内分泌肿瘤 2B 型具有不同的临床表型。
BMC Ophthalmol. 2023 Jun 12;23(1):260. doi: 10.1186/s12886-023-03005-0.
9
Identification of Novel Candidate Genes for Familial Thyroid Cancer by Whole Exome Sequencing.全外显子组测序鉴定家族性甲状腺癌的新候选基因。
Int J Mol Sci. 2023 Apr 25;24(9):7843. doi: 10.3390/ijms24097843.
10
Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study.丹麦1930 - 2021年2A型多内分泌腺瘤病中的原发性甲状旁腺功能亢进:一项基于全国人群的回顾性研究
Cancers (Basel). 2023 Apr 2;15(7):2125. doi: 10.3390/cancers15072125.